东海证券晨会纪要-2025-03-26

Key Recommendations - The food and beverage sector experienced a decline of 4.03% last week, underperforming the CSI 300 index by 1.74 percentage points, ranking 27th among 31 sectors [6] - The liquor segment is showing signs of improvement in supply-demand dynamics, with a year-on-year increase of 5.50% in retail sales of tobacco and alcohol for January-February 2025, despite a month-on-month decline of 4.90 percentage points [7] - The beer industry is expected to see demand improvements due to recent consumption-promoting policies, with stable or declining costs contributing positively to profitability [8] Food and Beverage Sector Insights - The liquor market is at a bottoming phase, with major brands maintaining stable pricing despite industry pressures, suggesting a potential recovery in demand [7] - The snack food sector is experiencing rapid growth due to diversified channels and innovative products, indicating continued industry growth potential [9] - The dairy sector is benefiting from policy support, with improving supply-demand dynamics for raw milk, suggesting a stabilization in milk prices [10] Pharmaceutical and Biotechnology Sector Insights - The pharmaceutical and biotechnology sector saw an overall decline of 1.41% last week, but has increased by 2.52% year-to-date, outperforming the CSI 300 index by 3.03 percentage points [12] - The basic medical insurance fund's total income and expenditure for 2024 were reported at 34,809.95 billion yuan and 29,675.92 billion yuan, respectively, indicating a year-on-year growth of 3.91% and 5.20% [13] - Future policies are expected to enhance the healthcare system's quality, with a focus on brand Chinese medicine, medical services, and innovative drug chains [14] Investment Recommendations - For the liquor sector, it is advised to focus on high-end brands and regional leaders such as Kweichow Moutai and Wuliangye [9] - In the beer sector, Qingdao Beer is highlighted as a core high-end investment target [8] - The snack food sector should consider companies with strong growth logic like Yanjinpuzi and Gan Yuan Food [10] - In the dairy sector, leading companies like Yili and New Dairy are recommended for investment [10] - The pharmaceutical sector suggests focusing on companies like Lingrui Pharmaceutical and Huaxia Eye Hospital for potential growth [15]